E-LIB Suche - Ergebnisse für: Crump, Lyndsey S. - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Targeting Tryptophan Catabolism in Ovarian Cancer to Attenu..:

Crump, Lyndsey S. ; Floyd, Jessica L. ; Kuo, Li-Wei...
Cancer Research Communications. 4 (2024) 3 - p. 822-833 , 2024

Link: https://doi.org/10.1158/..

2

Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukem..:

Kent, Andrew ; Crump, Lyndsey S. ; Davila, Eduardo
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2..:

Elias, Anthony D. ; Spoelstra, Nicole S. ; Staley, Alyse W....
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

NPC1 Confers Metabolic Flexibility in Triple Negative Breas..:

O'Neill, Kathleen I. ; Kuo, Li-Wei ; Williams, Michelle M....
Cancers. 14 (2022) 14 - p. 3543 , 2022

Link: https://doi.org/10.3390/..

5

Triple Targeting of Breast Tumors Driven by Hormonal Recept..:

Shagisultanova, Elena ; Crump, Lyndsey S. ; Borakove, Michelle...
Molecular Cancer Therapeutics. 21 (2021) 1 - p. 48-57 , 2021

Link: https://doi.org/10.1158/..

6

Cross-talk between SIM2s and NFκB regulates cyclooxygenase ..:

Wyatt, Garhett L. ; Crump, Lyndsey S. ; Young, Chloe M....
Breast Cancer Research. 21 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

7

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2..:

Elias, Anthony D ; Spoelstra, Nicole S ; Staley, Alyse W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199936/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukem..:

Kent, Andrew ; Crump, Lyndsey S ; Davila, Eduardo
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465706/. , 2023

Link: http://www.ncbi.nlm.nih...

9

NPC1 Confers Metabolic Flexibility in Triple Negative Breas..:

O'Neill, Kathleen I ; Kuo, Li-Wei ; Williams, Michelle M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319388/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Breast cancers co-opt normal mechanisms of tolerance to pro..:

Crump, Lyndsey S ; Kines, Kelsey T ; Richer, Jennifer K.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662806/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Triple targeting of breast tumors driven by hormonal recept..:

Shagisultanova, Elena ; Crump, Lyndsey S ; Borakove, Michelle...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742793/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Hormonal regulation of Semaphorin 7a in ER+ breast cancer d..:

Crump, Lyndsey S ; Wyatt, Garhett L ; Rutherford, Taylor R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878309/. , 2020

Link: http://www.ncbi.nlm.nih...

13

Semaphorin 7A promotes macrophage-mediated lymphatic remode..:

Elder, Alan M ; Tamburini, Beth AJ ; Crump, Lyndsey S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239927/. , 2018

Link: http://www.ncbi.nlm.nih...

14

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2..:

Anthony D. Elias ; Nicole S. Spoelstra ; Alyse W. Staley...
https://doi.org/10.1038/s41523-023-00544-z. , 2023

Link: https://doi.org/10.1038/..

15

Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukem..:

Andrew Kent ; Lyndsey S. Crump ; Eduardo Davila
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1202950/full. , 2023

Link: https://doi.org/10.3389/..

1-15